These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical trial of a new drug, analog of chlordiazepoxide, for treatment of anxiety and tension. Gilbert MM Int J Neuropsychiatry; 1965 Dec; 1(6):556-8. PubMed ID: 5886535 [No Abstract] [Full Text] [Related]
6. [Experiences in the use of SD 709 in the depressive syndrome]. Guth E; Hoffmann G Wien Klin Wochenschr; 1966 Jan; 78(1):14-6. PubMed ID: 5962851 [No Abstract] [Full Text] [Related]
7. Beyond depression. What do those "mood drugs" really do? Lemonick MD Time; 1999 May; 153(19):74. PubMed ID: 10387666 [No Abstract] [Full Text] [Related]
8. [Fixed-idea syndrome in the structure of psychopathies and psychopathy-like states (review of the literature)]. Gindikin VIa Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(5):754-9. PubMed ID: 899479 [No Abstract] [Full Text] [Related]
9. [Significance of cognitive disorders for the classification and behavior therapy of obsessive syndromes]. Süllwold L Nervenarzt; 1973 Oct; 44(10):537-46. PubMed ID: 4765909 [No Abstract] [Full Text] [Related]
14. [Practice guidelines--therapy of anxiety and compulsive disorders. Recommendations for therapy of anxiety and compulsive disorders of the Drug Commission of the German Medical Society]. Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):241-4. PubMed ID: 10802900 [No Abstract] [Full Text] [Related]
15. [Type analysis in 80 neurotic patients. (Differentiation of phobias from obsessive neuroses)]. Berendt H; Neumärker M; Nickel B Psychiatr Neurol Med Psychol (Leipz); 1971 Apr; 23(4):233-9. PubMed ID: 5115419 [No Abstract] [Full Text] [Related]
16. [Clinico-dynamic features of obsessive-phobic neurosis with onset during involution and old age]. Sergeev II Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(11):1681-6. PubMed ID: 726765 [TBL] [Abstract][Full Text] [Related]
18. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)]. Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J Encephale; 2001; 27(3):229-37. PubMed ID: 11488253 [TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders. Brady KT; Verduin ML Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091 [TBL] [Abstract][Full Text] [Related]
20. [Clinical and therapeutic considerations on the use of a benzodiazepine derivative, bromazepam (Ro 5-3350) in the treatment of obsessive-phobic disorders]. Salmoni G; Amati A; Giambelluca A; Vacca L Acta Neurol (Napoli); 1973; 28(5):588-609. PubMed ID: 4789497 [No Abstract] [Full Text] [Related] [Next] [New Search]